INOVIO PHARMACEUTICALS, INC. Research and Development Expense
INOVIO PHARMACEUTICALS, INC. (INO) reported Research and Development Expense of $10.83 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-12
- INOVIO PHARMACEUTICALS, INC. research and development expense for the quarter ending 2026-06-30 was $10.83M, a 25.44% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. research and development expense for the quarter ending 2026-03-31 was $14.07M, a 12.56% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. research and development expense for the quarter ending 2025-12-31 was $10.26M, a 20.37% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. research and development expense for the quarter ending 2025-09-30 was $13.33M, a 28.83% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. research and development expense for fiscal 2025 was $54.21M, a 28.32% decline from fiscal 2024.
- INOVIO PHARMACEUTICALS, INC. research and development expense for fiscal 2024 was $75.62M, a 12.76% decline from fiscal 2023.
- INOVIO PHARMACEUTICALS, INC. research and development expense for fiscal 2023 was $86.68M, a 53.81% decline from fiscal 2022.
- INOVIO PHARMACEUTICALS, INC. research and development expense for fiscal 2022 was $187.65M, a 24.71% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.83M 10-Q · filed 2026-08-12 | $24.90M 10-Q · filed 2026-08-12 | $35.16M derived: sum of 3 quarters · filed 2026-08-12 | $48.49M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $14.07M 10-Q · filed 2026-05-13 | $24.33M derived: sum of 2 quarters · filed 2026-05-13 | $37.66M derived: sum of 3 quarters · filed 2026-05-13 | $52.19M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $10.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $23.59M derived: sum of 2 quarters · filed 2026-03-12 | $38.12M derived: sum of 3 quarters · filed 2026-08-12 | $54.21M 10-K · filed 2026-03-12 |
| 2025-09-30 | $13.33M 10-Q · filed 2025-11-10 | $27.85M derived: sum of 2 quarters · filed 2026-08-12 | $43.95M 10-Q · filed 2025-11-10 | $56.83M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $14.52M 10-Q · filed 2026-08-12 | $30.61M 10-Q · filed 2026-08-12 | $43.50M derived: sum of 3 quarters · filed 2026-08-12 | $62.23M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $16.09M 10-Q · filed 2026-05-13 | $28.98M derived: sum of 2 quarters · filed 2026-05-13 | $47.71M derived: sum of 3 quarters · filed 2026-05-13 | $70.80M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $12.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $31.62M derived: sum of 2 quarters · filed 2026-03-12 | $54.71M derived: sum of 3 quarters · filed 2026-03-12 | $75.62M 10-K · filed 2026-03-12 |
| 2024-09-30 | $18.73M 10-Q · filed 2025-11-10 | $41.82M derived: sum of 2 quarters · filed 2025-11-10 | $62.73M 10-Q · filed 2025-11-10 | $79.99M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $23.09M 10-Q · filed 2025-08-12 | $44.00M 10-Q · filed 2025-08-12 | $61.26M derived: sum of 3 quarters · filed 2025-08-12 | $76.76M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $20.91M 10-Q · filed 2025-05-13 | $38.17M derived: sum of 2 quarters · filed 2025-05-13 | $53.67M derived: sum of 3 quarters · filed 2025-05-13 | $77.41M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $17.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $32.76M derived: sum of 2 quarters · filed 2025-03-18 | $56.50M derived: sum of 3 quarters · filed 2025-03-18 | $86.68M 10-K · filed 2025-03-18 |
| 2023-09-30 | $15.50M 10-Q · filed 2024-11-14 | $39.25M derived: sum of 2 quarters · filed 2024-11-14 | $69.42M 10-Q · filed 2024-11-14 | $111.54M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $23.74M 10-Q · filed 2024-08-08 | $53.92M 10-Q · filed 2024-08-08 | $96.04M derived: sum of 3 quarters · filed 2024-08-08 | $129.13M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $30.18M 10-Q · filed 2024-05-13 | $72.30M derived: sum of 2 quarters · filed 2024-05-13 | $105.38M derived: sum of 3 quarters · filed 2024-05-13 | $161.85M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $42.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $75.21M derived: sum of 2 quarters · filed 2024-03-06 | $131.67M derived: sum of 3 quarters · filed 2024-03-06 | $187.65M 10-K · filed 2024-03-06 |
| 2022-09-30 | $33.09M 10-Q · filed 2023-11-09 | $89.55M derived: sum of 2 quarters · filed 2023-11-09 | $145.53M 10-Q · filed 2023-11-09 | $237.83M derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-06-30 | $56.46M 10-Q · filed 2023-08-09 | $112.44M 10-Q · filed 2023-08-09 | $204.74M derived: sum of 3 quarters · filed 2024-03-06 | $251.83M derived: sum of 4 quarters · filed 2024-03-06 |
| 2022-03-31 | $55.98M 10-Q · filed 2023-05-10 | $148.28M derived: sum of 2 quarters · filed 2024-03-06 | $195.37M derived: sum of 3 quarters · filed 2024-03-06 | $266.17M derived: sum of 4 quarters · filed 2024-03-06 |
| 2021-12-31 | $92.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $139.39M derived: sum of 2 quarters · filed 2024-03-06 | $210.20M derived: sum of 3 quarters · filed 2024-03-06 | $249.24M 10-K · filed 2024-03-06 |
| 2021-09-30 | $47.09M 10-Q · filed 2022-11-08 | $117.90M derived: sum of 2 quarters · filed 2022-11-08 | $156.94M 10-Q · filed 2022-11-08 | $183.24M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $70.81M 10-Q · filed 2022-08-09 | $109.85M 10-Q · filed 2022-08-09 | $136.16M derived: sum of 3 quarters · filed 2022-08-09 | $162.61M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $39.04M 10-Q · filed 2022-05-10 | $65.35M derived: sum of 2 quarters · filed 2022-05-10 | $91.80M derived: sum of 3 quarters · filed 2022-05-10 | $114.18M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $26.30M 10-K · filed 2021-03-01 | $52.76M derived: sum of 2 quarters · filed 2021-11-09 | $75.13M derived: sum of 3 quarters · filed 2021-11-09 | $94.25M 10-K · filed 2023-03-01 |
| 2020-09-30 | $26.46M 10-Q · filed 2021-11-09 | $48.83M derived: sum of 2 quarters · filed 2021-11-09 | $67.94M 10-Q · filed 2021-11-09 | $89.95M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $22.38M 10-Q · filed 2021-08-09 | $41.49M 10-Q · filed 2021-08-09 | $63.49M derived: sum of 3 quarters · filed 2021-08-09 | $82.63M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $19.11M 10-Q · filed 2021-05-10 | $41.12M derived: sum of 2 quarters · filed 2021-05-10 | $60.25M derived: sum of 3 quarters · filed 2021-05-10 | $82.74M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $22.00M 10-K · filed 2021-03-01 | $41.14M derived: sum of 2 quarters · filed 2021-03-01 | $63.63M derived: sum of 3 quarters · filed 2021-03-01 | $88.02M 10-K · filed 2022-03-01 |
| 2019-09-30 | $19.14M 10-K · filed 2021-03-01 | $41.62M derived: sum of 2 quarters · filed 2021-03-01 | $66.01M 10-Q · filed 2020-11-09 | $92.38M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $22.49M 10-K · filed 2021-03-01 | $46.88M 10-Q · filed 2020-08-10 | $73.24M derived: sum of 3 quarters · filed 2021-03-01 | $95.09M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $24.39M 10-K · filed 2021-03-01 | $50.76M derived: sum of 2 quarters · filed 2021-03-01 | $72.61M derived: sum of 3 quarters · filed 2021-03-01 | $95.07M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $26.37M 10-K · filed 2020-03-12 | $48.22M derived: sum of 2 quarters · filed 2020-03-12 | $70.68M derived: sum of 3 quarters · filed 2020-03-12 | $95.26M 10-K · filed 2021-03-01 |
| 2018-09-30 | $21.85M 10-K · filed 2020-03-12 | $44.31M derived: sum of 2 quarters · filed 2020-03-12 | $68.89M 10-Q · filed 2019-11-12 | $93.53M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $22.46M 10-K · filed 2020-03-12 | $47.04M 10-Q · filed 2019-08-08 | $71.68M derived: sum of 3 quarters · filed 2020-03-12 | $97.19M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $24.58M 10-K · filed 2020-03-12 | $49.22M derived: sum of 2 quarters · filed 2020-03-12 | $74.73M derived: sum of 3 quarters · filed 2020-03-12 | $98.61M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | $24.64M 10-K · filed 2019-03-12 | $50.15M derived: sum of 2 quarters · filed 2019-03-12 | $74.03M derived: sum of 3 quarters · filed 2019-03-12 | $98.57M 10-K · filed 2020-03-12 |
| 2017-09-30 | $25.51M 10-K · filed 2019-03-12 | $49.39M derived: sum of 2 quarters · filed 2019-03-12 | $73.93M 10-Q · filed 2018-11-08 | $97.84M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | $23.88M 10-K · filed 2019-03-12 | $48.42M 10-Q · filed 2018-08-07 | $72.33M derived: sum of 3 quarters · filed 2019-03-12 | $99.31M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | $24.54M 10-K · filed 2019-03-12 | $48.45M derived: sum of 2 quarters · filed 2019-03-12 | $75.43M derived: sum of 3 quarters · filed 2019-03-12 | $95.07M derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | $23.91M 10-K · filed 2018-03-14 | $50.89M derived: sum of 2 quarters · filed 2018-03-14 | $70.52M derived: sum of 3 quarters · filed 2018-03-14 | $88.71M 10-K · filed 2019-03-12 |
| 2016-09-30 | $26.98M 10-K · filed 2018-03-14 | $46.61M derived: sum of 2 quarters · filed 2018-03-14 | $64.80M 10-Q · filed 2017-11-08 | $80.40M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $19.63M 10-K · filed 2018-03-14 | $37.82M 10-Q · filed 2017-08-08 | $53.42M derived: sum of 3 quarters · filed 2018-03-14 | $69.50M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $18.19M 10-K · filed 2018-03-14 | $33.79M derived: sum of 2 quarters · filed 2018-03-14 | $49.87M derived: sum of 3 quarters · filed 2018-03-14 | $66.55M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $15.60M 10-K · filed 2017-03-15 | $31.68M derived: sum of 2 quarters · filed 2017-03-15 | $48.37M derived: sum of 3 quarters · filed 2017-03-15 | $57.79M 10-K · filed 2018-03-14 |
| 2015-09-30 | $16.08M 10-K · filed 2017-03-15 | $32.76M derived: sum of 2 quarters · filed 2017-03-15 | $42.19M 10-Q · filed 2016-11-09 | $51.43M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $16.69M 10-K · filed 2017-03-15 | $26.11M 10-Q · filed 2016-08-08 | $35.36M derived: sum of 3 quarters · filed 2017-03-15 | $42.38M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | $9.43M 10-K · filed 2017-03-15 | $18.67M derived: sum of 2 quarters · filed 2017-03-15 | $25.69M derived: sum of 3 quarters · filed 2017-03-15 | $35.30M derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | $9.24M 10-K · filed 2016-03-14 | $16.26M derived: sum of 2 quarters · filed 2016-03-14 | $25.87M derived: sum of 3 quarters · filed 2016-03-14 | $34.10M 10-K · filed 2017-03-15 |
| 2014-09-30 | $7.02M 10-K · filed 2016-03-14 | $16.63M derived: sum of 2 quarters · filed 2016-03-14 | $24.85M 10-Q · filed 2015-11-09 | $31.25M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $9.61M 10-K · filed 2016-03-14 | $17.83M 10-Q · filed 2015-08-10 | $24.24M derived: sum of 3 quarters · filed 2016-03-14 | $29.68M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $8.23M 10-K · filed 2016-03-14 | $14.63M derived: sum of 2 quarters · filed 2016-03-14 | $20.07M derived: sum of 3 quarters · filed 2016-03-14 | $24.48M derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $6.40M 10-K · filed 2015-03-16 | $11.84M derived: sum of 2 quarters · filed 2015-03-16 | $16.25M derived: sum of 3 quarters · filed 2015-03-16 | $21.37M 10-K · filed 2016-03-14 |
| 2013-09-30 | $5.44M 10-K · filed 2015-03-16 | $9.85M derived: sum of 2 quarters · filed 2015-03-16 | $14.96M 10-Q · filed 2014-11-10 | $19.41M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-06-30 | $4.41M 10-K · filed 2015-03-16 | $9.53M 10-Q · filed 2014-08-11 | $13.97M derived: sum of 3 quarters · filed 2015-03-16 | $18.94M derived: sum of 4 quarters · filed 2015-03-16 |
| 2013-03-31 | $5.12M 10-K · filed 2015-03-16 | $9.56M derived: sum of 2 quarters · filed 2015-03-16 | $14.53M derived: sum of 3 quarters · filed 2015-03-16 | $19.06M derived: sum of 4 quarters · filed 2015-03-16 |
| 2012-12-31 | $4.44M 10-K · filed 2014-03-17 | $9.42M derived: sum of 2 quarters · filed 2014-03-17 | $13.94M derived: sum of 3 quarters · filed 2014-03-17 | $17.98M 10-K · filed 2015-03-16 |
| 2012-09-30 | $4.97M 10-K · filed 2014-03-17 | $9.50M derived: sum of 2 quarters · filed 2014-03-17 | $13.54M 10-Q · filed 2013-11-12 | $17.70M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | $4.53M 10-K · filed 2014-03-17 | $8.57M 10-Q · filed 2013-08-09 | $12.73M derived: sum of 3 quarters · filed 2014-03-17 | $19.72M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $4.04M 10-K · filed 2014-03-17 | $8.20M derived: sum of 2 quarters · filed 2014-03-17 | $15.19M derived: sum of 3 quarters · filed 2014-03-17 | $19.65M derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | $4.16M 10-K · filed 2013-03-18 | $11.15M derived: sum of 2 quarters · filed 2013-03-18 | $15.61M derived: sum of 3 quarters · filed 2013-03-18 | $20.03M 10-K · filed 2014-03-17 |
| 2011-09-30 | $6.99M 10-K · filed 2013-03-18 | $11.45M derived: sum of 2 quarters · filed 2013-03-18 | $15.87M 10-Q · filed 2012-11-07 | $20.37M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $4.46M 10-K · filed 2013-03-18 | $8.89M 10-Q · filed 2012-08-09 | $13.38M derived: sum of 3 quarters · filed 2013-03-18 | $16.33M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $4.42M 10-K · filed 2013-03-18 | $8.91M derived: sum of 2 quarters · filed 2013-03-18 | $11.86M derived: sum of 3 quarters · filed 2013-03-18 | $14.95M derived: sum of 4 quarters · filed 2013-03-18 |
| 2010-12-31 | $4.49M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $7.44M derived: sum of 2 quarters · filed 2013-03-18 | $10.53M derived: sum of 3 quarters · filed 2013-03-18 | $13.26M 10-K · filed 2013-03-18 |
| 2010-09-30 | $2.95M 10-Q · filed 2011-11-07 | $6.03M derived: sum of 2 quarters · filed 2011-11-07 | $8.76M 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $3.08M 10-Q · filed 2011-08-05 | $5.81M 10-Q · filed 2011-08-05 | ||
| 2009-12-31 | $9.41M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |